The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Transactions for brokerage firms
Represented one of the leading U.S.-based brokerage firms in commercial loan transactions for its brokerage customers; loans secured by real and more
Contract Dispute Arbitration for a publicly traded supplier of industrial parts
Represented a publicly traded supplier of industrial parts in the successful arbitration of a significant breach of contract dispute against one of more
Trademark portfolio management for Weather Group Television
Provides brand management and portfolio maintenance, advice, licensing, litigation and other assistance in connection with trademarks, copyrights, more
Zino Davidoff S.A. v. Holbrook Wholesalers Inc.
Obtained temporary restraining order and consent order enjoining sale of counterfeit and gray market DAVIDOFF fragrances, as well as significant more